皮膚筋炎博士論文 参考文献駆動執筆 医療(106)

血清学的非活動性皮膚筋炎の 臨床および筋病理組織楽的検討　平賢一郎　東京大学　博士(医学)
https://repository.dl.itc.u-tokyo.ac.jp/record/2002360/files/A36025.pdf

この資料は、医療システムを構築するために、オープンソースでプログラミングするための基礎資料です。


<この項は書きかけです。順次追記します。>
This article is not completed. I will add some words in order.

# Reference

1 Okinaka S, Sugita H, Momoi H, et al. Serum creatine phosphokinase and aldolase activity in neuromuscular disorders. Trans Am Neurol Assoc 1959; 84: 62–4.
2 Ljungdahl L, Gerhardt W. Creatine kinase isoenzyme variants in human serum. Clin Chem 1978; 24: 832–4.
3 Dalakas MC. Polymyositis, Dermatomyositis, and Inclusion-Body Myositis. N Engl J Med 1991; 325: 1487–98.
4 Chahin N, Selcen D, Engel AG. Sporadic late onset nemaline myopathy. Neurology. 2005; 65: 1158–64.
5 Rosalki SB. Low serum creatine kinase activity. Clin. Chem. 1998; 44: 905.
6 Longo DL, Dalakas MC. Inflammatory Muscle Diseases. N Engl J Med 2015; 372: 1734–47.
7 Lilleker JB, Vencovsky J, Wang G, et al. The EuroMyositis registry: An international collaborative tool to facilitate myositis research. Ann Rheum Dis 2018; 77: 30–9.
8 E W. Fall einer seltenen Muskelkrankheit. Arch Heilkd 1863; 4: 282.
9 JACKSON H. Myositis Universalis Acuta Infectiosa, with a Case. Bost Med Surg J 1887; 116: 498–9.
10 H U. Polymyositis acuta progressiva. Z Klin Med 1887; 12: 533.
11 H U. Dermatomyositis acuta. Dtsch med Wochenschr 1891; 17: 41.
12 Bohan A, Peter JB. Polymyositis and Dermatomyositis. N Engl J Med 1975; 292: 344–7.
13 Devere R, Bradley WG. Polymyositis: Its presentation, morbidity and mortality. Brain 1975; 98: 637–66.
14 Bohan A, Peter JB, Bowman RL, Pearson CM. Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore) 1977; 56: 255–86.
15 Gerami P, Schope JM, McDonald L, Walling HW, Sontheimer RD. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis sine myositis): A missing link within the spectrum of the idiopathic inflammatory myopathies. J. Am. Acad. Dermatol. 2006; 54: 597–613.
16 Hoogendijk JE, Amato AA, Lecky BR, et al. 119th ENMC international workshop: Trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands. Neuromuscul Disord 2004; 14: 337–45.
17 Lundberg IE, Tjärnlund A, Bottai M, et al. EULAR/ACR Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and their Major Subgroups. Ann Rheum Dis 2017; 69: 1–12.
18 Benveniste O, Stenzel W, Allenbach Y. Advances in serological diagnostics of inflammatory myopathies. Curr Opin Neurol 2016; 29: 662–73.
19 Allenbach Y, Benveniste O. Diagnostic utility of auto-antibodies in inflammatory muscle diseases. J. Neuromuscul. Dis. 2015; 2: 13–25.
20 Allenbach Y, Benveniste O, Goebel HH, Stenzel W. Integrated classification of inflammatory myopathies. Neuropathol. Appl. Neurobiol. 2017; 43: 62–81.
21 Fujimoto M, Watanabe R, Ishitsuka Y, Okiyama N. Recent advances in dermatomyositis-specific autoantibodies. Curr Opin Rheumatol 2016; 28: 636– 44.
22 McHugh NJ, Tansley SL. Autoantibodies in myositis. Nat Rev Rheumatol 2018; 14: 290–302.
23 Ichimura Y, Matsushita T, Hamaguchi Y, et al. Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: Possible association with malignancy. Ann Rheum Dis 2012; 71: 710–3.
24 Fujimoto M, Matsushita T, Hamaguchi Y, et al. Autoantibodies to small ubiquitin-like modifier activating enzymes in Japanese patients with dermatomyositis: comparison with a UK Caucasian cohort. Ann Rheum Dis 2013; 72: 151–3.
25 Muro Y, Sugiura K, Akiyama M. Low prevalence of anti-small ubiquitin-like modifier activating enzyme antibodies in dermatomyositis patients. Autoimmunity 2013; 46: 279–84.
26 Sato S, Hirakata M, Kuwana M, et al. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum 2005; 52: 1571–6.
27 Hoshino K, Muro Y, Sugiura K, Tomita Y, Nakashima R, Mimori T. Anti-MDA5 and anti-TIF1-γ antibodies have clinical significance for patients with dermatomyositis. Rheumatology 2010; 49: 1726–33.
28 Bailey EE, Fiorentino DF. Amyopathic Dermatomyositis: Definitions, Diagnosis, and Management. Curr. Rheumatol. Rep. 2014; 16: 465.
29 Lahoria R, Selcen D, Engel AG. Microvascular alterations and the role of complement in dermatomyositis. Brain 2016; 139: 1891–903.
30 Hida A, Yamashita T, Hosono Y, et al. Anti-TIF1-γ antibody and cancer-associated myositis: A clinicohistopathologic study. Neurology 2016; 87: 299–308.
31 Greenberg SA, Pinkus JL, Pinkus GS, et al. Interferon-α/β-mediated innate immune mechanisms in dermatomyositis. Ann Neurol 2005; 57: 664–78.
32 Uruha A, Nishikawa A, Tsuburaya RS, et al. Sarcoplasmic MxA expression. Neurology 2016; 88: 493–500.
33 Krain L. Dermatomyositis in six patients without initial muscle involvement. Arch Dermatol 1975; 111: 241–5.
34 Fudman EJ, Schnitzer TJ. Dermatomyositis without creatine kinase elevation. A poor prognostic sign. Am J Med 1986; 80: 329–32.
35 Euwer RL, Sontheimer RD. Amyopathic dermatomyositis (dermatomyositis sine myositis). Presentation of six new cases and review of the literature. J Am Acad Dermatol 1991; 24: 959–66.
36 El-Azhary RA, Pakzad SY. Amyopathic dermatomyositis: Retrospective review of 37 cases. J. Am. Acad. Dermatol. 2002; 46: 560–5.
37 Sontheimer RD. Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis siné myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J Am Acad Dermatol 2002; 46: 626–36.
38 Bendewald MJ, Wetter DA, Li X, Davis MDP. Incidence of dermatomyositis and clinically amyopathic dermatomyositis: a population-based study in Olmsted County, Minnesota. Arch Dermatol 2010; 146: 26–30.
39 Sontheimer RD. MDA5 autoantibody-another indicator of clinical diversity in dermatomyositis. Ann Transl Med 2017; 5: 160–160.
40 Hamaguchi Y, Fujimoto M, Matsushita T, et al. Common and Distinct Clinical Features in Adult Patients with Anti-Aminoacyl-tRNA Synthetase Antibodies: Heterogeneity within the Syndrome. PLoS One 2013; 8: e60442.
41 Trallero-Araguás E, Rodrigo-Pendás JÁ, Selva-O’Callaghan A, et al. Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: A systematic review and meta-analysis. Arthritis Rheum. 2012; 64: 523–32.
42 Gunawardena H, Wedderburn LR, North J, et al. Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis. Rheumatology 2008; 47: 324–8.
43 Rider LG, Shah M, Mamyrova G, et al. The myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine (Baltimore) 2013; 92: 223–43.
44 Sato S, Hoshino K, Satoh T, et al. RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease. Arthritis Rheum 2009; 60: 2193–200.
45 Nakashima R, Imura Y, Kobayashi S, et al. The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody. Rheumatology 2009; 49: 433–40.
46 Kato H, Takeuchi O, Sato S, et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006; 441: 101–5.
47 Moghadam-Kia S, Oddis C V, Sato S, Kuwana M, Aggarwal R. Antimelanoma Differentiation-associated Gene 5 Antibody: Expanding the Clinical Spectrum in North American Patients with Dermatomyositis. J Rheumatol 2017; : jrheum.160682.
48 Allenbach Y, Leroux G, Suárez-Calvet X, et al. Dermatomyositis with or without anti-melanoma differentiation-associated gene 5 antibodies common interferon signature but distinct NOS2 expression. Am J Pathol 2016; 186: 691–700.
49 Nozaki K, Pestronk A. High aldolase with normal creatine kinase in serum predicts a myopathy with perimysial pathology. J Neurol Neurosurg Psychiatry 2009; 80: 904–8.
50 Casciola-Rosen L, Hall JC, Mammen AL, Christopher-Stine L, Rosen A. Isolated elevation of aldolase in the serum of myositis patients: A potential biomarker of damaged early regenerating muscle cells. Clin Exp Rheumatol 2012; 30: 548–53.
51 El-Dokla AM, Aggarwal R, Oddis C V, Ali ST, Lacomis D. Histopathologic Findings in 5 Patients With Hypomyopathic Dermatomyositis: The Importance of MHC-1 Expression on Myofibers. J Clin Neuromuscul Dis 2015; 17: 52–8.
52 Troyanov Y, Targoff IN, Payette M-P, et al. Redefining Dermatomyositis. Medicine (Baltimore) 2014; 93: 296–310.
53 239 􁕳: 25–9.
54 Maeda MH, Tsuji S, Shimizu J. Inflammatory myopathies associated with anti-mitochondrial antibodies. Brain 2012; 135: 1767–77.
55 Kadoya M, Hida A, Hashimoto Maeda M, et al. Cancer association as a risk factor for anti-HMGCR antibody-positive myopathy. Neurol Neuroimmunol neuroinflammation 2016; 3: e290.
56 Ikenaga C, Kubota A, Kadoya M, et al. Clinicopathologic features of myositis patients with CD8-MHC-1 complex pathology. Neurology 2017; 89: 1060–8.
57 􁶫􁮏􁫂􁏊. 􂞽􂅖􂮬􁕫􁢠􀰯􀠾􀡼􀡧􁢠􀣑􀢺􀢥􀣥􀢻􀣜􀢔􁢠􀰯􀢆􁭷􀡍􀡿􂅖􂑕􁛶􂞽 􂑌􁝈􀡢􂮫􁗋􀠊􂑓􂌮􁏛􂓗􂉉􁚩􀡟􃛵􀡍􀡿􁳨􃂦. 􁮾􀮿􁊱􁏛􀼤􁊈􃄽􁩥 2010; 􂏥􂞨 25943􀾕.
58 Mathur T, Manadan AM, Thiagarajan S, Hota B, Block JA. The utility of serum aldolase in normal creatine kinase dermatomyositis. J Clin Rheumatol 2014; 20: 47–8.
59 Bachasson D, Landon-Cardinal O, Benveniste O, Hogrel J-Y, Allenbach Y. Physical activity monitoring: A promising outcome measure in idiopathic inflammatory myopathies. Neurology 2017; 89: 101–3.
60 Pfister PB, De Bruin ED, Sterkele I, Maurer B, De Bie RA, Knols RH. Manual muscle testing and hand-held dynamometry in people with inflammatory myopathy: An intra- and interrater reliability and validity study. PLoS One 2018; 13: e0194531.
61 Hall JC, Casciola-Rosen L, Samedy LA, et al. Anti-melanoma differentiation-associated protein 5-associated dermatomyositis: Expanding the clinical spectrum. Arthritis Care Res 2013; 65: 1307–15.
62 Chen Z, Cao M, Plana MN, et al. Utility of anti-melanoma differentiation-associated gene 5 antibody measurement in identifying patients with dermatomyositis and a high risk for developing rapidly progressive interstitial lung disease: A review of the literature and a meta-analysis. Arthritis Care Res 2013; 65: 1316–24.
63 Mamyrova G, Kishi T, Targoff IN, Ehrlich A, Curiel R V, Rider LG. Features distinguishing clinically amyopathic juvenile dermatomyositis from juvenile dermatomyositis. Rheumatology (Oxford) 2018; 57: 1956–63.
64 Kagen LJ, Aram S. Creatine kinase activity inhibitor in sera from patients with muscle disease. Arthritis Rheum 1987; 30: 213–7.
65 Fréret M, Drouot L, Obry A, et al. Overexpression of MHC class i in muscle of lymphocyte-deficient mice causes a severe myopathy with induction of the unfolded protein response. Am J Pathol 2013; 183: 893–904.
66 Vitadello M, Doria A, Tarricone E, Ghirardello A, Gorza L. Myofiber stress-response in myositis: parallel investigations on patients and experimental animal models of muscle regeneration and systemic inflammation. Arthritis Res　Ther 2010; 12: R52.
67 Lightfoot AP, Nagaraju K, McArdle A, Cooper RG. Understanding the origin of　non-immune cell-mediated weakness in the idiopathic inflammatory myopathies　- potential role of ER stress pathways. Curr Opin Rheumatol 2015; 27: 580–5.
68 Englund P, Lindroos E, Nennesmo I, Klareskog L, Lundberg IE. Skeletal muscle　fibers express major histocompatibility complex class II antigens independently　of inflammatory infiltrates in inflammatory myopathies. Am J Pathol 2001; 159:1263–73.
69 Lightfoot AP, McArdle A, Jackson MJ, Cooper RG. In the idiopathic　inflammatory myopathies (IIM), do reactive oxygen species (ROS) contribute to　muscle weakness? Ann Rheum Dis 2015; 74: 1340–6.
70 Harris-Love MO, Shrader JA, Koziol D, et al. Distribution and severity of　weakness among patients with polymyositis, dermatomyositis and juvenile　dermatomyositis. Rheumatology 2009; 48: 134–9.
71 Varsani H, Charman SC, Li CK, et al. Validation of a score tool for measurement　of histological severity in juvenile dermatomyositis and association with clinical　severity of disease. Ann Rheum Dis 2015; 74: 204–10

## Reference 1 of the Reference 
https://pubmed.ncbi.nlm.nih.gov/13730599/

## Reference 2 of the Reference 
https://pubmed.ncbi.nlm.nih.gov/647919/

Dalakas MC, ed. Polymyositis and dermatomyositis. Boston: Butterworths, 1988
2. Carpenter S, Karpati G. . The major inflammatory myopathies of unknown cause . Pathol Annu 1981;16:205–37　
3. Banker BQ, Engel AG. The polymyositis and dermatomyositis syndromes. In: Engel AG, Banker BQ, eds. Myology. New York: McGraw-Hill, 1986:1385–422
4. Rowland LP, ed. Merritt's textbook of neurology. 8th ed. Philadelphia: Lea & Febiger, 1989:733–8
5. Whitaker JN. . Inflammatory myopathy: a review of etiologic and pathogenetic factors . Muscle Nerve 1982;5:573–92
6. Dalakas MC. . Inflammatory myopathies . Curr Opin Neurol Neurosurg 1990;3:689–96
7. Plotz PH, Dalakas M, Leff RL, Love LA, Miller FW, Cronin ME. . Current concepts in the idiopathic inflammatory myopathies: polymyositis, dermatomyositis and related disorders . Ann Intem Med 1989:111:143–57
8. Karpati G, Carpenter S. . Idiopathic inflammatory myopathies . Curr Opin Neurol Neurosurg 1988;1:806–14
9. Ansell BM, ed. . Inflammatory diseases of muscle . Clin Rheum Dis 1984;10:1–215
10. Mastaglia FL, Ojeda VJ. . Inflammatory myopathies: part 1 . Ann Neurol 1985;17:215–27
11. Engel AG, Emslie-Smith AM. . Inflammatory myopathies . Curr Opin Neurol Neurosurg 1989;2:695–700
Google Scholar. opens in new tab
12. Walton J. . The idiopathic inflammatory myopathies and their treatment . J Neurol Neurosurg Psychiatry 1991;54:285–7
13. Pearson CM, Bohan A. . The spectrum of polymyositis and dermatomyositis . Med Clin North Am 1977;61:439–57
14. Bohan A, Peter JB. . Polymyositis and dermatomyositis . N Engl J Med 1975;292:344–7, 403–7
15. Carpenter S, Karpati G, Heller I, Eisen A. . Inclusion body myositis: a distinct variety of idiopathic inflammatory myopathy . Neurology 1978;28:8–17
16. Medsger TA, Dawson WN, Masi AT. . The epidemiology of polymyositis . Am J Med 1979;48:715–23
17. Franks AG Jr. . Important cutaneous markers of dermatomyositis . J Musculoskeletal Med 1988;5(9):39–63
Google Scholar. opens in new tab
18. Stahl NI, Klippel JH, Decker JL. . A cutaneous lesion associated with myositis . Ann Intern Med 1979;91:577–9
Crossref. opens in new tab
19. Dalakas MC. A classification of polymyositis and dermatomyositis. In: Dalakas MC, ed. Polymyositis and dermatomyositis. Boston: Butterworths, 1988:1–16
Google Scholar. opens in new tab
20. Idem. Polymyositis and dermatomyositis: an overview. In: Dalakas MC, ed. Polymyositis and dermatomyositis. Boston: Butterworths, 1988:327–36
Google Scholar. opens in new tab
21. Bunch TW. . Polymyositis: a case history approach to the differential diagnosis and treatment . Mayo Clin Proc 1990;65:1480–97
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
22. Banker BQ. Parasitic myositis and other inflammatory myopathies. In: Engel AG, Banker BQ, eds. Myology. New York: McGraw-Hill, 1986:1467–524
Google Scholar. opens in new tab
23. Hertzman PA, Blevins WL, Mayer J, Greenfield B, Ting M, Gleich GJ. . Association of the eosinophilia—myalgia syndrome with the ingestion of tryptophan . N Engl J Med 1990;322:869–73
Free Full Text
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
24. Shevell M, Rosenblatt B, Silver K, Carpenter S, Karpati G. . Congenital inflammatory myopathy . Neurology 1990;40:1111–4
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
25. Doyle DR, McCurley TL, Sergent JS. . Fatal polymyositis in D-penicillamine-treated rheumatoid arthritis . Ann Intern Med 1983;98:327–30
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
26. Dalakas MC, Illa I, Pezeshkpour GH, Laukaitis JP, Cohen B, Griffin JL. . Mitochondrial myopathy caused by long-term zidovudine therapy . N Engl J Med 1990;322:1098–105
Free Full Text
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
27. Mastaglia FL. . Adverse effects of drugs on muscle . Drugs 1982;24:304–21
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
28. Engel WK, Dalakas MC. Treatment of neuromuscular diseases. In: Wiederhold WC, ed. Therapy for neurologic diseases. New York: John Wiley, 1982:51–101
Google Scholar. opens in new tab
29. Shepherd JJ. . Tropical myositis: is it an entity and what is its cause? Lancet 1983;2:1240–2
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
30. Gaut P, Wong PK, Myer RD. . Pyomyositis in a patient with the acquired immunodeficiency syndrome . Arch Intern Med 1988;148:1608–10
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
31. Atlas E, Novak SN, Duray PH, Steere achéal. . Lyme myositis: muscle invasion by Borrelia burgdorferi . Ann Intern Med 1988;109:245–6
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
32. Warner CL, Fayad PB, Heffner RR Jr. . Legionella myositis . Neurology 1991;41:750–2
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
33. Mikol J. Inclusion body myositis. In: Engel AG, Banker BQ, eds. Myology. New York: McGraw-Hill, 1986:1423–38
Google Scholar. opens in new tab
34. Eisen A, Berry K, Gibson G. . Inclusion body myositis: myopathy or neuropathy? Neurology 1983;33:1109–14
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
35. Lotz BP, Engel AG, Nishino H, Stevens JC, Litcy WJ. . Inclusion body myositis . Brain 1989;112:727–42
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
36. Cole AJ, Kuzniecky R, Karpati G, et al. . Familial myopathy with changes resembling inclusion body myositis and periventricular leucoencephalopathy . Brain 1988;111:1025–37
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
37. Massa R, Weiler B, Karpati G, Shoubridge E, Carpenter S. . Familial inclusion body myositis among Kurdish-Iranian Jews . Arch Neurol 1991;48: 519–22
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
38. Dietz F, Logeman JA, Sahgal V, Schmid FR. . Cricopharyngeal muscle dysfunction in the differential diagnosis of dysphagia in polymyositis . Arthritis Rheum 1980;23:491–5
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
39. DeMerieux P, Verity MA, Clements PJ, Paulus HE. . Esophageal abnormalities and dysphagia in polymyositis and dermatomyositis: clinical, radiographic and pathologic features . Arthritis Rheum 1983;26:961–8
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
40. Denbow CE, Lie JT, Tancredi RG, Bunch TW. . Cardiac involvement in polymyositis: a clinicopathologic study of 20 autopsied patients . Arthritis Rheum 1979;22:1088–92
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
41. Haupt HM, Hutchins GM. . The heart and cardiac conduction system in polymyositis-dermatomyositis: a clinicopathologic study of 16 autopsied patients . Am J Cardiol 1982;50:998–1006
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
42. Askari AD. . Cardiac abnormalities . Clin Rheum Dis 1984;10:31–149
Google Scholar. opens in new tab
43. Tymms KE, Webb J. . Dermatopolymyositis and other connective tissue diseases: a review of 105 cases . J Rheumatol 1985;12:1140–8
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
44. Hochberg MC, Feldman D, Stevens MB. . Adult onset polymyositis/dermatomyositis: an analysis of clinical and laboratory features and survival in 76 patients with a review of the literature . Semin Arthritis Rheum 1986;15: 168–78
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
45. Salmeron G, Greenberg SD, Lidsky MD. . Polymyositis and diffuse interstitial lung disease: a review of the pulmonary histopathologic findings . Arch Intern Med 1981;141:1005–10
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
46. Tazelaar HD, Viggiano RW, Pickersgill J, Colby TV. . Interstitial lung disease in polymyositis and dermatomyositis: clinical features and prognosis as correlated with histologic findings . Am Rev Respir Dis 1990; 141:727–33
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
47. Caro I. . Dermatomyositis as a systemic disease . Med Clin North Am 1989;73:1181–92
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
48. Lakhanpal S, Lie JT, Conn DL, et al. . Pulmonary disease in polymyositis/ dermatomyositis: a clinicopathological analysis of 65 autopsy cases . Ann Rheum Dis 1987;46:23–9
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
49. Bernstein RM, Morgan SH, Chapman J, et al. . Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease . BMJ 1984;289:151–2
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
50. Barnes BE. . Dermatomyositis and malignancy: a review of the literature . Ann Intern Med 1976;84:68–76
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
51. Callen JP. . Malignancy in polymyositis/dermatomyositis . Clin Dermatol 1988;2:55–63
Crossref. opens in new tab
Google Scholar. opens in new tab
52. Manchul LA, Jin A, Pritchard KI, et al. . The frequency of malignant neoplasms in patients with polymyositis-dermatomyositis: a controlled study . Arch Intern Med 1985;145:1835–9
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
53. Lakhanpal S, Bunch TW, Ilstrup DM, Melton LJ III. . Polymyositis-dermatomyositis and malignant lesions: does an association exist? Mayo Clin Proc 1986;61:645–53
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
54. Richardson JB, Callen JP. . Dermatomyositis and malignancy . Med Clin North Am 1989;73:1211–20
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
55. Callen JP. . The value of malignancy evaluation in patients with dermatomyositis . J Am Acad Dermatol 1982;6:253–9
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
56. Mimori T. . Scleroderma-polymyositis overlap syndrome: clinical and serologic aspects . Int J Dermatol 1987;26:419–25
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
57. Bohan A, Peter JB, Bowman RL, Pearson CM. . Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis . Medicine (Baltimore) 1977;56:255–86
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
58. Rosenberg NL, Carry MR, Ringel SP. Association of inflammatory myopathies with other connective tissue disorders and malignancies. In: Dalakas MC, ed. Polymyositis and dermatomyositis. Boston: Butterworths, 1988: 37–69
Google Scholar. opens in new tab
59. Sharp GC. Mixed connective tissue disease. In: Wilson JD, Braunwald E, Isselbacher KJ, eds. Harrison's principles of internal medicine. 12th ed. Vol. 2. New York: McGraw-Hill, 1991:1448–9
Google Scholar. opens in new tab
60. Targoff IN. . Immunologic aspects of myositis . Curr Opin Rheumatol 1989; 1:432–42
Crossref. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
61. Genth E, Mierau R, Genetzky P, et al. . Immunogenetic associations of scleroderma-related antinuclear antibodies . Arthritis Rheum 1990;33:657–65
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
62. Kagen LJ, Aram S. . Creatine kinase activity inhibitor in sera from patients with muscle disease . Arthritis Rheum 1987;30:213–7
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
63. Kagen LJ. . Myoglobinemia in inflammatory myopathies . JAMA 1977; 237:1448–52
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
64. Barkhaus PE, Nandedkar SD, Sanders DB. . Quantitative EMG in inflammatory myopathy . Muscle Nerve 1990;13:247–53
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
65. Uncini A, Lange DJ, Hayes AP, et al. . Long-duration polyphasic motor unit potentials in myopathies: a quantitative study with pathological correlation . Muscle Nerve 1990;13:263–7
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
66. Robinson LR. . Polymyositis . Muscle Nerve 1991;14:310–5
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
67. Carpenter S. Resin histology and electron microscopy in inflammatory myopathies. In: Dalakas MC, ed. Polymyositis and dermatomyositis. Boston: Butterworths, 1988:195–215
Google Scholar. opens in new tab
68. Arahata K, Engel AG. . Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells . Ann Neurol 1984;16:193–208
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
69. Engel AG, Arahata K. . Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases and implications for the pathogenesis of the different inflammatory myopathies . Hum Pathol 1986;17:704–21
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
70. Ringel SP, Carry MR, Aquilera AJ, Starcevich JM. . Quantitative histopathology of the inflammatory myopathies . Arch Neurol 1986;43:1004–9
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
71. Whitaker JN, Engel WK. . Vascular deposits of immunoglobulin and complement in idiopathic inflammatory myopathy . N Engl J Med 1972;286: 333–8
Full Text
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
72. Kissel JT, Mendell JR, Rammohan KW. . Microvascular deposition of complement membrane attack complex in dermatomyositis . N Engl J Med 1986;314:329–34
Full Text
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
73. Emslie-Smith AM, Engel AG. . Microvascular changes in early and advanced dermatomyositis: a quantitative study . Ann Neurol 1990;27:343–56
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
74. Kissel JT, Halterman RK, Rammohan KW, Mendel JR. . The relationship of complement-mediated microvasculopathy to the histologic features and clinical duration of disease in dermatomyositis . Arch Neurol 1991;48:26–30
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
75. Engel AG, Arahata K. . Monoclonal antibody analysis of mononuclear cells in myopathies. II. Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis . Ann Neurol 1984;16:209–15
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
76. Karpati G, Pouliot Y, Carpenter S. . Expression of immunoreactive major histocompatibility complex products in human skeletal muscles . Ann Neurol 1988;23:64–72
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
77. Arahata K, Engel AG. . Monoclonal antibody analysis of mononuclear cells in myopathies. V: Identification and quantitation of T8+ cytotoxic and T8+ suppressor cells . Ann Neurol 1988;23:493–9
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
78. Emslie-Smith AM, Arahata K, Engel AG. . Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes and T-cell-mediated cytotoxicity in myopathies . Hum Pathol 1989;20: 224–31
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
79. Hohlfeld R, Engel AG. . Coculture with autologous myotubes of cytotoxic T cells isolated from muscle in inflammatory myopathies . Ann Neurol 1991;29:498–507
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
80. Hohlfeld R, Engel AG, Ii K, Harper MC. . Polymyositis mediated by T lymphocytes that express the γ/δ receptor . N Engl J Med 1991;324:877–81
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
81. Targoff IN, Arnett FC. . Clinical manifestations in patients with antibody to PL-12 antigen (alanyl-tRNA synthetase) . Am J Med 1990;88:241–51
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
82. Targoff IN. . Immune mechanisms of myositis . Curr Opin Rheumatol 1990;2:882–8
Crossref. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
83. Mathews MB, Bernstein RM. . Myositis autoantibody inhibits histidyl-tRNA synthetase: a model for autoimmunity . Nature 1983;304:177–9
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
84. Mathews MB, Reichlin M, Hughes GR, Bernstein RM. . Anti-threonyl-tRNA synthetase, a second myositis-related autoantibody . J Exp Med 1984;160:420–34
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
85. Bunn CC, Bernstein RM, Mathews MB. . Autoantibodies against alanyl-tRNA synthetase and tRNAA1a coexist and are associated with myositis . J Exp Med 1986;163:1281–91
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
86. Amett FC, Hirsch TJ, Bias WB, Nishikai M, Reichlin M. . The Jo-1 antibody system in myositis: relationships to clinical features and HLA . J Rheumatol 1981;8:925–30
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
87. Hochberg MC, Feldman D, Stevens MB, Arnett FC, Reichlin M. . Antibody to Jo-1 in polymyositis/dermatomyositis: association with interstitial pulmonary disease . J Rheumatol 1984;11:663–5
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
88. Targoff IN, Arnett FC, Berman L, O'Brien C, Reichlin M. . Anti-KJ:a new antibody associated with the syndrome of polymyositis and interstitial lung disease . J Clin Invest 1989;84:162–72
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
89. Arnett FC. . HLA genes and predisposition to rheumatic diseases . Hosp Pract [Off] 1986;21(12):89–100
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
90. Ruff RL. Acute viral myositis, virus-induced immune complex myositis and myoglobinuria. In: Vinken PJ, Bruyn GW, Klawans HL, McKendall RR, eds. Viral disease. Vol. 56 of Handbook of clinical neurology. Amsterdam: Elsevier Science, 1989:193–206
Google Scholar. opens in new tab
91. Hays AP, Gamboa ET. Acute viral myositis. In: Engel AG, Banker BQ, eds. Myology. New York: McGraw-Hill, 1986:1439–66
Google Scholar. opens in new tab
92. Denman AM. Viral etiology of polymyositis/dermatomyositis. In: Dalakas MC, ed. Polymyositis and dermatomyositis. Boston: Butterworths, 1988:97–120
Google Scholar. opens in new tab
93. Walker EJ, Jeffrey PD. . Sequence homology between encephalomyocarditis virus protein VPI and histidyl-tRNA synthetase supports a hypothesis of molecular mimicry in polymyositis . Med Hypotheses 1988;25:21–6
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
94. Bowles NE, Dubowitz V, Sewry CA, Archard LC. . Dermatomyositis, polymyositis, and Coxsackie-B-virus infection . Lancet 1987;1:1004–7
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
95. Rosenberg NL, Rotbart HA, Abzug MJ, Ringel SP, Levin MJ. . Evidence for a novel picornavirus in human dermatomyositis . Ann Neurol 1989;26: 204–9
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
96. Yousef GE, Isenberg DA, Mowbray JF. . Detection of enterovirus specific RNA sequences in muscle biopsy specimens from patients with adult onset myositis . Ann Rheum Dis 1990;49:310–5
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
97. Chou SM. . Inclusion body myositis: a chronic persistent mumps myositis . Hum Pathol 1986;17:765–77
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
98. Nishino H, Engel AG, Rima BK. . Inclusion body myositis: the mumps virus hypothesis . Ann Neurol 1989;25:260–4
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
99. Dalakas MC, London WT, Gravell M, Sever JL. . Polymyositis in an immunodeficiency disease in monkeys induced by a type D retrovirus . Neurology 1986;36:569–72
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
100. Dalakas MC, Gravell M, London WT, Cunningham G, Sever JL. . Morphological changes of an inflammatory myopathy in rhesus monkeys with simian acquired immunodeficiency syndrome . Proc Soc Exp Biol Med 1987;185:368–76
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
101. Dalakas MC, Pezeshkpour GH, Gravell M, Sever JL. . Polymyositis in patients with AIDS . JAMA 1986;256:2381–3
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
102. Dalakas MC, Pezeshkpour GH. . Neuromuscular diseases associated with human immunodeficiency virus infection . Ann Neurol 1988;23:Suppl: S38–S48
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
103. Dalakas M, Illa I. HIV-associated myopathies. In: Pizzo A, Wilfelt CM, eds. Pediatric AIDS. Baltimore: Williams & Wilkins, 1991:420–9
Google Scholar. opens in new tab
104. Simpson DM, Bender AN. . Human immunodeficiency virus-associated myopathy: analysis of 11 patients . Ann Neurol 1988;24:79–84
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
105. Illa I, Nath A, Dalakas MC. . Immunocytochemical and virological characteristics of HIV-associated inflammatory myopathies: similarities with seronegative polymyositis . Ann Neurol 1991;29:474–81
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
106. Lamperth L, Illa I, Dalakas M. . In situ hybridization in muscle biopsies from patients with HIV-associated polymyositis (HIV-PM) using labeled HIV-RNA probes . Neurology 1990;40:Suppl 1:121. abstract
Google Scholar. opens in new tab
107. Leon-Monzon MEL, Dalakas M. . Detection of HIV in muscle and nerve biopsies by DNA-amplification techniques . Neurology 1991;41:Suppl 1: 376. abstract
Google Scholar. opens in new tab
108. Lamperth L, Vicenzi E, Dalakas M. . Infection and transfection of human muscle by HIV or HIV proviral-DNA construct . Neurology 1991;41: Suppl 1:211. abstract
Google Scholar. opens in new tab
109. Morgan O, Rodgers-Johnson P, Mora C, Char G. . HTLV-I and polymyositis in Jamaica . Lancet 1989;2:1184–7
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
110. Wiley CA, Nerenberg M, Cros D, Soto-Aguilar MC. . HTLV-I polymyositis in a patient also infected with the human immunodeficiency virus . N Engl J Med 1989;320:992–5
Full Text
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
111. Rucheton M, Graafland H, Fanton H, Ursule L, Ferrier P, Larsen CJ. . Presence of circulating antibodies against gag-gene MuLV proteins in patients with autoimmune connective tissue disorders . Virology 1985;144: 468–80
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
112. Arnaudo E, Dalakas M, Shanske S, Moraes CR, DiMauro S, Schon EA. . Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy . Lancet 1991;337:508–10
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
113. Dalakas M, Lamperth L, Dagani F. . Abnormal muscle mitochondria induced by AZT in vitro and in an animal model: morphological, enzymatic and oxygen-consumption studies . Neurology 1991;41:Suppl 1:375. abstract
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
114. Henriksson KG, Sandstedt P. . Polymyositis — treatment and prognosis: a study of 107 patients . Acta Neurol Scand 1982;65:280–300
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
115. Uchino M, Araki S, Yoshida O, Uekawa K, Nagata J. . High single-dose alternate-day corticosteroid regimens in treatment of polymyositis . J Neurol 1985;232:175–8
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
116. Dalakas MC. Treatment of polymyositis and dermatomyositis with corticosteroids: a first therapeutic approach. In: Dalakas MC, ed. Polymyositis and dermatomyositis. Boston: Butterworths, 1988:235–53
Google Scholar. opens in new tab
117. Idem. Treatment of polymyositis and dermatomyositis . Curr Opin Rheumatol 1989;1:443–9
Crossref. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
118. Idem. Pharmacologic concerns of corticosteroids in the treatment of patients with immune-related neuromuscular diseases. Neurol Clin 1990;8: 93–118
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
119. Oddis CV, Medsger TA. . Relationship between serum creatine kinase level and corticosteroid therapy in polymyositis/dermatomyositis . J Rheumatol 1988;15:807–11
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
120. Bunch TW, Worthington JW, Combs JJ, Duane M, Ilstrup MS, Engel AG. . Azathioprine with prednisone for polymyositis: a controlled, clinical trial . Ann Intern Med 1980;92:365–9
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
121. Bunch TW. . Prednisone and azathioprine for polymyositis: long-term follow-up . Arthritis Rheum 1981;24:45–8
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
122. Metzger AL, Bohan A, Goldberg LS, Bluestone R, Pearson CM. . Polymyositis and dermatomyositis: combined methotrexate and corticosteroid therapy . Ann Intern Med 1974;81:182–9
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
123. Niakan E, Pitner SE, Whitaker JN, Bertorini TE. . Immunosuppressive agents in corticosteroid-refractory childhood dermatomyositis . Neurology 1980;30:286–91
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
124. Wallace DJ, Metzger AL, White KK. . Combination immunosuppressive treatment of steroid-resistant dermatomyositis/polymyositis . Arthritis Rheum 1985;28:590–2
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
125. Bunch TW. . The therapy of polymyositis . Mt Sinai J Med 1988;55:483–6
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
126. Bombardieri S, Hughes GRV, Neri R, Del Bravo P, Del Bono L. . Cyclophosphamide in severe polymyositis . Lancet 1989;1:1138–9
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
127. Cronin ME, Miller FW, Hicks JE, Dalakas M, Plotz PH. . The failure of intravenous cyclophosphamide therapy in refractory idiopathic inflammatory myopathy . J Rheumatol 1989;16:1225–8
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
128. Heckmatt J, Hasson N, Saunders C, et al. . Cyclosporin in juvenile dermatomyositis . Lancet 1989;1:1063–6
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
129. Dau PC. . Plasmapheresis in idiopathic inflammatory myopathy: experience with 35 patients . Arch Neurol 1981;38:544–52
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
130. Jones DW, Snaith ML, Isenberg DA. . Cyclosporine treatment for intractable polymyositis . Arthritis Rheum 1987;30:959–60
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
131. Engel WK, Lichter AS, Galdi AP. . Polymyositis: remarkable response to total body irradiation . Lancet 1981;1:658
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
132. Hubbard WN, Walport MJ, Hainan KE, Beaney RP, Hughes GRV. . Remission from polymyositis after total body irradiation . BMJ 1982;284: 1915–6
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
133. Kelly JJ, Madoc-Jones H, Adelman LS, Andres PL, Munsat TL. . Response to total body irradiation in dermatomyositis . Muscle Nerve 1988;11:120–3
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
134. Dalakas MC, Engel WK. Total body irradiation in the treatment of intractable polymyositis/dermatomyositis. In: Dalakas MC, ed. Polymyositis and dermatomyositis. Boston: Butterworths, 1988:281–91
Google Scholar. opens in new tab
135. Kelly JJ Jr, Madoc-Jones H, Adelman LS, Andres PL, Munsat TL. . Total body irradiation not effective in inclusion body myositis . Neurology 1986;36:1264–6
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
136. Jan S, Beretta S, Maggio M, Alobbati L, Pellegrini G. . High-dose intravenous human immunoglobulin in treatment-resistant polymyositis . Neurology 1990;40:Suppl 1:120. abstract
Google Scholar. opens in new tab
137. Roifman CM, Schaffer FM, Wachsmuth SE, Murphy G, Gelfand EW. . Reversal of chronic polymyositis following intravenous immune serum globulin therapy . JAMA 1987;258:513–5
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
138. Cherin P, Herson S, Wechsler B, et al. . Intravenous immunoglobulin for polymyositis and dermatomyositis . Lancet 1990;336:116
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
139. Rowland LP, Clark C, Olartc M. . Therapy for dermatomyositis and polymyositis . Adv Neurol 1977;17:63–97
Medline. opens in new tab
Google Scholar. opens in new tab
140. al-Janadi M, Smith CD, Karsh J. . Cyclophosphamide treatment of interstitial pulmonary fibrosis in polymyositis/dermatomyositis . J Rheumatol 1989;16:1592–6
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
141. Munsat TL, Piper D, Cancilla P, Mednick J. . Inflammatory myopathy with facioscapulohumeral distribution . Neurology 1972;22:335–47
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
142. Wulff JD, Lin JT, Kepes JJ. . Inflammatory facioscapulohumeral muscular dystrophy and Coats syndrome . Ann Neurol 1982;12:398–401
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar. opens in new tab
143. Hudgson P, Fulthorpe JJ. . The pathology of type II skeletal muscle glycogenosis: a light and electron-microscopic study . J Pathol 1975;116:139–47
Crossref. opens in new tab
Web of Science. opens in new tab
Medline. opens in new tab
Google Scholar

Related Services
https://myaccount.nejm.org/

皮膚筋炎博士論文　参考文献駆動執筆
https://qiita.com/kaizen_nagoya/items/29a69c75eb830b8ef791

薬の追跡調査：副作用。 膠原病皮膚筋炎
https://qiita.com/kaizen_nagoya/items/2e69e729537f55826d74

血液検査・健康診断、データサイエンティストの自己データ管理。携帯計画者日記(14)
https://qiita.com/kaizen_nagoya/items/b3956b639368877eb199


## Engineering Festa 2024前に必読記事一覧
登壇直後版 色使い(JIS安全色) Qiita Engineer Festa 2023〜私しか得しないニッチな技術でLT〜 スライド編 0.15
https://qiita.com/kaizen_nagoya/items/f0d3070d839f4f735b2b

プログラマが知っていると良い「公序良俗」
https://qiita.com/kaizen_nagoya/items/9fe7c0dfac2fbd77a945

逆も真：社会人が最初に確かめるとよいこと。OSEK(69)、Ethernet(59)
https://qiita.com/kaizen_nagoya/items/39afe4a728a31b903ddc

統計の嘘。仮説（127）
https://qiita.com/kaizen_nagoya/items/63b48ecf258a3471c51b

自分の言葉だけで論理展開できるのが天才なら、文章の引用だけで論理展開できるのが秀才だ。仮説（136）
https://qiita.com/kaizen_nagoya/items/97cf07b9e24f860624dd

参考文献駆動執筆(references driven writing)・デンソークリエイト編
https://qiita.com/kaizen_nagoya/items/b27b3f58b8bf265a5cd1

「何を」よりも「誰を」。１０年後のために今見習いたい人たち
https://qiita.com/kaizen_nagoya/items/8045978b16eb49d572b2

Qiitaの記事に３段階または５段階で到達するための方法
https://qiita.com/kaizen_nagoya/items/6e9298296852325adc5e

出力(output)と呼ばないで。これは状態(state)です。
https://qiita.com/kaizen_nagoya/items/80b8b5913b2748867840

coding (101) 一覧を作成し始めた。omake:最近のQiitaで表示しない5つの事象
https://qiita.com/kaizen_nagoya/items/20667f09f19598aedb68

あなたは「勘違いまとめ」から、勘違いだと言っていることが勘違いだといくつ見つけられますか。人間の間違い(human error(125))の種類と対策
https://qiita.com/kaizen_nagoya/items/ae391b77fffb098b8fb4

プログラマの「プログラムが書ける」思い込みは強みだ。３つの理由。仮説（168）統計と確率(17) , OSEK(79)
https://qiita.com/kaizen_nagoya/items/bc5dd86e414de402ec29

出力(output)と呼ばないで。これは状態(state)です。
https://qiita.com/kaizen_nagoya/items/80b8b5913b2748867840

これからの情報伝達手段の在り方について考えてみよう。炎上と便乗。
https://qiita.com/kaizen_nagoya/items/71a09077ac195214f0db

ISO/IEC JTC1 SC7 Software and System Engineering
https://qiita.com/kaizen_nagoya/items/48b43f0f6976a078d907

アクセシビリティの知見を発信しよう！（再び）
https://qiita.com/kaizen_nagoya/items/03457eb9ee74105ee618

統計論及確率論輪講（再び）
https://qiita.com/kaizen_nagoya/items/590874ccfca988e85ea3

読者の心をグッと惹き寄せる7つの魔法
https://qiita.com/kaizen_nagoya/items/b1b5e89bd5c0a211d862

「@kazuo_reve 新人の方によく展開している有益な情報」確認一覧
https://qiita.com/kaizen_nagoya/items/b9380888d1e5a042646b

ソースコードで議論しよう。日本語で議論するの止めましょう（あるプログラミング技術の議論報告）
https://qiita.com/kaizen_nagoya/items/8b9811c80f3338c6c0b0

脳内コンパイラの3つの危険
https://qiita.com/kaizen_nagoya/items/7025cf2d7bd9f276e382

心理学の本を読むよりはコンパイラ書いた方がよくね。仮説（34）
https://qiita.com/kaizen_nagoya/items/fa715732cc148e48880e

NASAを超えるつもりがあれば読んでください。
https://qiita.com/kaizen_nagoya/items/e81669f9cb53109157f6

データサイエンティストの気づき!「勉強して仕事に役立てない人。大嫌い!!」『それ自分かも?』ってなった!!! 
https://qiita.com/kaizen_nagoya/items/d85830d58d8dd7f71d07

「ぼくの好きな先生」「人がやらないことをやれ」プログラマになるまで。仮説（37）　
https://qiita.com/kaizen_nagoya/items/53e4bded9fe5f724b3c4

なぜ経済学徒を辞め、計算機屋になったか（経済学部入学前・入学後・卒業後対応） 転職(1)  
https://qiita.com/kaizen_nagoya/items/06335a1d24c099733f64    

プログラミング言語教育のXYZ。 仮説（52） 
https://qiita.com/kaizen_nagoya/items/1950c5810fb5c0b07be4

【24卒向け】9ヶ月後に年収１０００万円を目指す。二つの関門と三つの道。
https://qiita.com/kaizen_nagoya/items/fb5bff147193f726ad25

「【25卒向け】Qiita Career Meetup for STUDENT」予習の勧め
https://qiita.com/kaizen_nagoya/items/00eadb8a6e738cb6336f

大学入試不合格でも筆記試験のない大学に入って卒業できる。卒業しなくても博士になれる。
https://qiita.com/kaizen_nagoya/items/74adec99f396d64b5fd5

全世界の不登校の子供たち「博士論文」を書こう。世界子供博士論文遠隔実践中心 安全(99)
https://qiita.com/kaizen_nagoya/items/912d69032c012bcc84f2

小川メソッド　覚え（書きかけ）
https://qiita.com/kaizen_nagoya/items/3593d72eca551742df68

DoCAP（ドゥーキャップ）って何ですか？
https://qiita.com/kaizen_nagoya/items/47e0e6509ab792c43327

views 20,000越え自己記事一覧
https://qiita.com/kaizen_nagoya/items/58e8bd6450957cdecd81

Views１万越え、もうすぐ１万記事一覧 最近いいねをいただいた213記事
https://qiita.com/kaizen_nagoya/items/d2b805717a92459ce853

# 関連資料
' @kazuo_reve 私が効果を確認した「小川メソッド」
https://qiita.com/kazuo_reve/items/a3ea1d9171deeccc04da

' @kazuo_reve 新人の方によく展開している有益な情報
https://qiita.com/kazuo_reve/items/d1a3f0ee48e24bba38f1

' @kazuo_reve Vモデルについて勘違いしていたと思ったこと
https://qiita.com/kazuo_reve/items/46fddb094563bd9b2e1e

# 自己記事一覧
Qiitaで逆リンクを表示しなくなったような気がする。時々、スマフォで表示するとあらわっることがあり、完全に削除したのではなさそう。

４月以降、せっせとリンクリストを作り、統計を取って確率を説明しようとしている。
2025年２月末を目標にしている。

物理記事　上位100
https://qiita.com/kaizen_nagoya/items/66e90fe31fbe3facc6ff

量子(0) 計算機, 量子力学 
https://qiita.com/kaizen_nagoya/items/1cd954cb0eed92879fd4

数学関連記事１００
https://qiita.com/kaizen_nagoya/items/d8dadb49a6397e854c6d

統計(0)一覧
https://qiita.com/kaizen_nagoya/items/80d3b221807e53e88aba

図(0) state, sequence and timing. UML and お絵描き 
https://qiita.com/kaizen_nagoya/items/60440a882146aeee9e8f

品質一覧 
https://qiita.com/kaizen_nagoya/items/2b99b8e9db6d94b2e971

言語・文学記事　１００
https://qiita.com/kaizen_nagoya/items/42d58d5ef7fb53c407d6

医工連携関連記事一覧
https://qiita.com/kaizen_nagoya/items/6ab51c12ba51bc260a82

自動車　記事　１００
https://qiita.com/kaizen_nagoya/items/f7f0b9ab36569ad409c5

通信記事１００
https://qiita.com/kaizen_nagoya/items/1d67de5e1cd207b05ef7

日本語（０）一欄
https://qiita.com/kaizen_nagoya/items/7498dcfa3a9ba7fd1e68

英語(0) 一覧
https://qiita.com/kaizen_nagoya/items/680e3f5cbf9430486c7d

転職(0)一覧
https://qiita.com/kaizen_nagoya/items/f77520d378d33451d6fe

仮説（0）一覧（目標100現在40）
https://qiita.com/kaizen_nagoya/items/f000506fe1837b3590df

音楽　一覧(0) 
https://qiita.com/kaizen_nagoya/items/b6e5f42bbfe3bbe40f5d

「@kazuo_reve 新人の方によく展開している有益な情報」確認一覧 
https://qiita.com/kaizen_nagoya/items/b9380888d1e5a042646b

Qiita(0)Qiita関連記事一覧（自分）
https://qiita.com/kaizen_nagoya/items/58db5fbf036b28e9dfa6

鉄道（０）鉄道のシステム考察はてっちゃんがてつだってくれる
https://qiita.com/kaizen_nagoya/items/26bda595f341a27901a0

安全（0）安全工学シンポジウムに向けて: 21
https://qiita.com/kaizen_nagoya/items/c5d78f3def8195cb2409

一覧の一覧( The directory of directories of mine.) Qiita(100)
https://qiita.com/kaizen_nagoya/items/7eb0e006543886138f39

Ethernet 記事一覧　Ethernet(0)
https://qiita.com/kaizen_nagoya/items/88d35e99f74aefc98794

Wireshark 一覧 wireshark(0)、Ethernet(48) 
https://qiita.com/kaizen_nagoya/items/fbed841f61875c4731d0

線網（Wi-Fi）空中線(antenna)(0) 記事一覧(118/300目標)
https://qiita.com/kaizen_nagoya/items/5e5464ac2b24bd4cd001

OSEK OS設計の基礎　OSEK(100)
https://qiita.com/kaizen_nagoya/items/7528a22a14242d2d58a3

Error一覧 error(0)
https://qiita.com/kaizen_nagoya/items/48b6cbc8d68eae2c42b8

C++ Support(0)　
https://qiita.com/kaizen_nagoya/items/8720d26f762369a80514

Coding(0) Rules, C, Secure, MISRA and so on
https://qiita.com/kaizen_nagoya/items/400725644a8a0e90fbb0

coding (101) 一覧を作成し始めた。omake:最近のQiitaで表示しない5つの事象
https://qiita.com/kaizen_nagoya/items/20667f09f19598aedb68

プログラマによる、プログラマのための、統計(0)と確率のプログラミングとその後
https://qiita.com/kaizen_nagoya/items/6e9897eb641268766909

なぜdockerで機械学習するか 書籍・ソース一覧作成中 (目標100)
https://qiita.com/kaizen_nagoya/items/ddd12477544bf5ba85e2

言語処理100本ノックをdockerで。python覚えるのに最適。:10+12
https://qiita.com/kaizen_nagoya/items/7e7eb7c543e0c18438c4

プログラムちょい替え（0）一覧:4件
https://qiita.com/kaizen_nagoya/items/296d87ef4bfd516bc394

Python(0)記事をまとめたい。
https://qiita.com/kaizen_nagoya/items/088c57d70ab6904ebb53

官公庁・学校・公的団体（NPOを含む）システムの課題、官（０）
https://qiita.com/kaizen_nagoya/items/04ee6eaf7ec13d3af4c3

「はじめての」シリーズ　 ベクタージャパン　
https://qiita.com/kaizen_nagoya/items/2e41634f6e21a3cf74eb

AUTOSAR(0)Qiita記事一覧, OSEK(75)
https://qiita.com/kaizen_nagoya/items/89c07961b59a8754c869

プログラマが知っていると良い「公序良俗」
https://qiita.com/kaizen_nagoya/items/9fe7c0dfac2fbd77a945

LaTeX(0) 一覧　
https://qiita.com/kaizen_nagoya/items/e3f7dafacab58c499792

自動制御、制御工学一覧（０）
https://qiita.com/kaizen_nagoya/items/7767a4e19a6ae1479e6b

Rust(0) 一覧　
https://qiita.com/kaizen_nagoya/items/5e8bb080ba6ca0281927

100以上いいねをいただいた記事16選
https://qiita.com/kaizen_nagoya/items/f8d958d9084ffbd15d2a

小川清最終講義、最終講義（再）計画, Ethernet(100) 英語(100) 安全(100)
https://qiita.com/kaizen_nagoya/items/e2df642e3951e35e6a53


### 文書履歴(document history)
ver. 0.01 初稿 　20240225
### 最後までおよみいただきありがとうございました。
いいね　💚、フォローをお願いします。
#### Thank you very much for reading to the last sentence.
Please press the like icon 💚　and follow me for your happy life.